跳至主要内容
临床试验/NL-OMON54673
NL-OMON54673招募中3 期

Atosiban versus placebo in the treatment of late threatened preterm birth (APOSTEL VIII). - APOSTEL VIII

Academisch Medisch Centrum0 个研究点目标入组 745 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
745

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women >= 18 years old with a singleton or twin pregnancy with a gestational age
  • between 30 0/7 and 33 6/7 weeks with threatened preterm birth defined by
  • regular uterine contractions, and one of the following:
  • - Cervical length of <= 15 mm or
  • - Cervical length of 15-30 mm and a positive fFn test or in case of absence of
  • cervical length measurement in local protocol a positive Fibronectin test or
  • Partus test
  • - Ruptured amniotic membranes

排除标准

  • - Previous treatment for threatened preterm birth with corticosteroids in
  • current pregnancy.
  • - Contra indication for tocolysis
  • - Signs of fetal distress
  • - Signs of intra uterine infection
  • - Fetal chromosomal or severe congenital abnormalities

研究者

相似试验